NeuroGenesis
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
410 White Spruce Blvd, Rochester, New Yo...Website
www.neurogenesis-cell.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About NeuroGenesis
NeuroGenesis is a clinical stage cellular therapy company dedicated to developing innovative treatments for neurodegenerative diseases, specifically targeting conditions like progressive multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). Their proprietary NG CELL platform utilizes enhanced bone marrow stem cells to create remyelinating and regenerative biofactory cells that aim to slow or halt neurodegeneration. The company focuses on delivering sustained levels of therapeutic proteins to promote the regeneration of myelin and neuronal cells, improving the quality of life for patients. With a strong emphasis on advanced cellular therapy, NeuroGenesis is positioned to pioneer new hope and cures in the field of neurodegenerative disease treatment.Explore more
NeuroGenesis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeuroGenesis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on NeuroGenesis recently announced quarterly report
Product Launch: Get notified when NeuroGenesis launches new products
Click to see if NeuroGenesis had a recent Job posting/layoffs
Check out if NeuroGenesis is spiking on competitors!
Funding: Get notified immidiatlly once NeuroGenesis has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if NeuroGenesis has recently received funding, and reach out quickly before it becomes old news!
NeuroGenesis, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at NeuroGenesis
Recommended Actions
Find VP level buyers at NeuroGenesis
Find more new buyers
Compare Similar Companies to NeuroGenesis
Compare insights from companies similar to NeuroGenesis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NeuroGenesis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NeuroGenesis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NeuroGenesis.
NeuroGenesis Tech Stack
A closer look at the technologies used by NeuroGenesis
NeuroGenesis News & Media
NeuroGenesis Awarded Grant from National MS Society’s Fast Forward Program to Advance Cell Therapy & Phase IIb Trial
NeuroGenesis has been awarded a grant from the National MS Society to advance its NG01 cell therapy and launch its Phase IIb trial for secondary progressive MS. ROCHESTER, NY, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- NeuroGenesis, a clinical- …
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NeuroGenesis
Sign Up For FreeTo access detailed company insights
NeuroGenesis is a clinical stage cellular therapy company dedicated to developing innovative treatments for neurodegenerative diseases, specifically targeting conditions like progressive multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). Their proprietary NG CELL platform utilizes enhanced bone marrow stem cells to create remyelinatin... Read More
